TIMES ARROW
HCA Holdings Inc(HCA)
Exchange:NYSE
Sector:Healthcare
Industry:
Medical Care Facilities
Operation:
Domestic
IPO Date:
2011-03-10
Employees:
220,000
Url:
https://www.hcahealthcare.com
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Financial Ratios Overview (2023)
Current Ratio
1.18
Acid-Test Ratio
1.02
Cash Ratio
0.07
Operating Cash Flow Ratio
0.75
Debt Ratio
-7.13
Interest Coverage Ratio
4.97
Debt Service Coverage Ratio
0.24
Asset Turnover Ratio
1.16
Inventory Turnover Ratio
4.9
Receivable Turnover Ratio
6.52
Days Sales in Inventory Ratio
5 days
Gross Margin Ratio
0.85
Operating Margin Ratio
0.15
Return on Assets Ratio
0.09
Return on Equity Ratio
-2.95
Book Value per Share Ratio
0.01
Earnings per Share Ratio
-4.89
Histroric Financial Stats
We are finding ways to improve data quality all the time. Please report any data related issue to cliffgoslinginc@gmail.com.
20232022202120202019
Total Revenue
64.97 B
60.23 B
58.75 B
51.53 B
51.34 B
Cost of Revenue
-9.9 B
-9.37 B
-9.48 B
-8.37 B
-8.48 B
Gross Profit
55.07 B
50.86 B
49.27 B
43.16 B
42.86 B
Operating Expenses
-45.44 B
-41.81 B
-39.59 B
-35.9 B
-35.64 B
Total Expenses
-55.34 B
-51.18 B
-49.07 B
-44.27 B
-44.12 B
Operating Income
9.63 B
9.1 B
9.79 B
7.32 B
7.26 B
Total Other Income
17 M
-518 M
42 M
-1.89 B
-2.02 B
Pretax Income
7.71 B
8.58 B
9.83 B
5.43 B
5.24 B
Tax Provision
-1.62 B
-1.75 B
-2.11 B
-1.04 B
-1.1 B
Net Income Common Shareholders
0
5.64 B
6.96 B
3.75 B
3.51 B
EBIT
9.65 B
9.1 B
9.79 B
7.32 B
7.26 B
EBITDA
12.73 B
12.07 B
12.64 B
10.04 B
9.86 B
Reconciled Depreciation
-3.08 B
-2.97 B
-2.85 B
-2.72 B
-2.6 B
Common Stock Shares Outstanding
276.41 M
294.67 M
328.75 M
343.61 M
348.23 M
Diluted EPS
0
19.15
21.16
10.93
10.07
Minority Interest
-849 M
-1.19 B
-765 M
633 M
640 M
Projected Return on Equity
Disclaimer: the predictions are generated from AI models trained on financial statements data of all US common stocks in the past 40 years.
Expected Value: 64.83%
Curve fitting error: 0.8242
Projected Return on Assets
Disclaimer: the predictions are generated from AI models trained on financial statements data of all US common stocks in the past 40 years.
Expected Value: 10.92%
Curve fitting error: 0.0059
@2024 by Times Arrow (cliffgoslinginc@gmail.com)
Terms and Conditions|Privacy